MarcS.RudoltzMD

PubMed

• 9 citations
  First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors.
  Filip Janku, Seung-Hoon Beom, Yong Wha Moon, Tae Won Kim, Young G Shin, Dong-Seok Yim, Gun Min Kim, Hyo Song Kim, Sun Young Kim, Jae-Ho Cheong, Young Woo Lee, Barb Gei...> ;Investigational New Drugs. 2022 Oct 1
• 14 citations
  Repression of LKB1 by miR-17∼92 Sensitizes MYC-Dependent Lymphoma to Biguanide Treatment.
  Said Izreig, Alexandra Gariepy, Irem Kaymak, Hannah R. Bridges, Ariel O. Donayo, Gaëlle Bridon, Lisa DeCamp, Susan M. Kitchen-Goosen, Daina Avizonis, Ryan D. Sheldon, ...> ;Cell Reports. Medicine. 2020 May 19
• Application of Magnetic Resonance Imaging and Three-Dimensional Treatment Planning in the Treatment of Orbital Lymphoma.
  Rudoltz MS, Ayyangar K, Mohiuddin M> ;Med Dosim. 2015-01-01
• 8 citations
  Effects of yogurt and applesauce on the oral bioavailability of nilotinib in healthy volunteers.
  Ophelia Q. P. Yin, Marc Rudoltz, Ivana Galetic, Jeiry Filian, Arun Krishna, Wei Zhou, Joseph M. Custodio, Georg Golor, Horst Schran> ;Journal of Clinical Pharmacology. 2011 Nov 1
• 362 citations
  Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized St...
  Timothy P. Hughes, Andreas Hochhaus, Susan Branford, Martin C. Müller, Jaspal Kaeda, Letizia Foroni, Brian J. Druker, François Guilhot, Richard A. Larson, Stephen G. O...> ;Blood. 2010 Nov 11
• 207 citations
  Phase III, Randomized, Open-Label Study of Daily Imatinib Mesylate 400 mg Versus 800 mg in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia...
  Jorge E. Cortes, Michele Baccarani, François Guilhot, Brian J. Druker, Susan Branford, Dong-Wook Kim, Fabrizio Pane, Ricardo Pasquini, Stuart L. Goldberg, Matt Kalayci...> ;Journal of Clinical Oncology. 2010 Jan 20
• 641 citations
  Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia.
  Andreas Hochhaus, Stephen G. O'Brien, François Guilhot, B. J. Druker, Susan Branford, Letizia Foroni, JohnM. Goldman, Martin C. Müller, Jerald P. Radich, Marc Rudoltz,...> ;Leukemia. 2009 Mar 12
• 85 citations
  Efficacy of Imatinib Dose Escalation in Patients With Chronic Myeloid Leukemia in Chronic Phase
  Hagop M. Kantarjian, Richard A. Larson, François Guilhot, Stephen G. O'Brien, Manisha Mone, Marc Rudoltz, Tillmann Krahnke, Jorge E. Cortes, Brian J. Druker> ;Cancer. 2009 Feb 1
• Satraplatin, an oral platinum analog, is active and synergistic with paclitaxel and docetaxel in prostate carcinoma models.
  Lamphere L, Obermayr F, Caligiuri M, Unteregger G, Rudoltz MS, Wosikowksi K, Casazza AM> ;J. Clin. Oncol.. 2006-06-20
• 34 citations
  Phase 1 study of weekly polyethylene glycol-camptothecin in patients with advanced solid tumors and lymphomas.
  James Posey, M. Wasif Saif, Ronda Carlisle, Andrew Goetz, Jinee Rizzo, Suzanne Stevenson, Marc S. Rudoltz, Joseph Kwiatek, Paul J. Simmons, Eric K. Rowinsky, Chris H. ...> ;Clinical Cancer Research. 2005 Nov 1
• Pegamotecan (EZ-246), a novel PEGylated camptothecin conjugate, for treatment of adenocarcinomas of the stomach and gastroesophageal (GE) junction: Preliminary results...
  Scott LC, Evans T, Yao JC, Benson AI, Mulcahy M, Thomas A, Decatris M, Falk S, Rudoltz M, Ajani JA> ;J. Clin. Oncol.. 2004-07-15
• 31 citations
  High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx.
  Marc S. Rudoltz, Ryan S. Perkins, Robert W. Luthmann, Todd D. Fracke, Tina M. Green, Linda Moye, Peter Wludyka, Young‐Ku Choi, Scot N. Ackerman> ;The Laryngoscope. 1999 Dec 1
• 19 citations
  Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
  Daniel J. Canaday, William F. Regine, Mohammed Mohiuddin, William Zollinger, Mitchell Machtay, Jason Lee, Delray Schultz, Marc S. Rudoltz> ;Radiation Oncology Investigations. 1999 Jan 1
• 43 citations
  Second malignant neoplasia in patients with T1 glottic cancer treated with radiation
  Mihoko Fujita, Marc S. Rudoltz, Daniel J. Canady, Pushpa Patel, Mitchell Machtay, Melissa Q. Pittard, Mohammed Mohiuddin, William F. Regine> ;The Laryngoscope. 1998 Dec 1
• 12 citations
  High-dose-rate brachytherapy with a custom-surface mold to treat recurrent squamous cell carcinomas of the skin of the forearm
  Marc S. Rudoltz, Ryan S. Perkins, Robert W. Luthmann, Todd D. Fracke, Tina M. Green, N. Fred Eaglstein, Lisa G. Hochman, Scot N. Ackerman> ;Journal of the American Academy of Dermatology. 1998 Jun 1
• 18 citations
  Multiple causes of cerebrovascular events in children with tumors of the parasellar region.
  Marc S. Rudoltz, William F. Regine, James W. Langston, Robert A. Sanford, Edward H. Kovnar, Larry E. Kun> ;Journal of Neuro-Oncology. 1998 May 1
• 16 citations
  Molecular Biology of the Cell Cycle: Potential for Therapeutic Applications in Radiation Oncology.
  Marc S. Rudoltz, Gary D. Kao, Kenneth R. Blank, Ruth J. Muschel, W. Gillies McKenna> ;Seminars in Radiation Oncology. 1996 Oct 1
• 59 citations
  Radiotherapy for merkel cell carcinoma of the skin of the head and neck
  Mohan Suntharalingam, Marc S. Rudoltz, William M. Mendenhall, James T. Parsons, Scott P. Stringer, Rodney R. Million> ;Head & Neck. 1995 Mar 1
• 32 citations
  Does pathologic node status affect local control in patients with carcinoma of the head and neck treated with radical surgery and postoperative radiotherapy
  Marc S. Rudoltz, Alia Benammar, Mohammed Mohiuddin> ;International Journal of Radiation Oncology, Biology, Physics. 1995 Feb 1
• 1 citations
  Is hyperfractionation really better
  Marc S. Rudoltz, Mohammed Mohiuddin> ;Radiotherapy and Oncology. 1993 Dec 1
• 93 citations
  Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis
  Marc S. Rudoltz, Alia Benammar, Mohammed Mohiuddin> ;International Journal of Radiation Oncology, Biology, Physics. 1993 Aug 1
• Application of magnetic resonance imaging and three-dimensional treatment planning in the treatment of orbital lymphoma.
  M S Rudoltz, K Ayyangar, M Mohiuddin> ;Medical Dosimetry. 1993 Jan 1
• The molecular regulation of apoptosis and implications for radiation oncology.
  Blank, K. R., Rudoltz, M. S., Kao, G. D., Muschel, R. J., McKenna, W. G.> ;Int J Radiat Biol. 1997 May
• Regulation of radiation-induced apoptosis in oncogene-transfected fibroblasts: influence of H-ras on the G2 delay.
  McKenna, W. G., Bernhard, E. J., Markiewicz, D. A., Rudoltz, M. S., Maity, A., Muschel, R. J.> ;Oncogene. 1996 Jan 18
• Staging of head and neck cancer.
  Kao, G. D., Rudoltz, M.> ;N Engl J Med. 1995 Jun 29
• Join now to see all